MedPath

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

Phase 3
Terminated
Conditions
Systemic Lupus Erythematosus
Interventions
Drug: Baricitinib
Drug: Placebo
Registration Number
NCT03843125
Lead Sponsor
Eli Lilly and Company
Brief Summary

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1147
Inclusion Criteria
  • Have completed the final treatment study visit of an originating study, such as study JAHZ (NCT03616912) or Study JAIA (NCT03616964).
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo to 2 mg BaricitinibPlaceboParticipants who received placebo in the originating study (JAHZ or JAIA) were randomized to receive 2 mg Baricitinib administered orally QD.
Placebo to 4 mg BaricitinibPlaceboParticipants who received placebo in the originating study (JAHZ or JAIA) were randomized to receive 4 mg Baricitinib administered orally QD.
4 mg BaricitinibPlaceboParticipants received one 4 mg Baricitinib tablet and one placebo tablet matching 2 mg Baricitinib administered orally QD.
2 mg BaricitinibPlaceboParticipants received one 2 mg Baricitinib tablet and one placebo tablet matching 4 mg Baricitinib administered orally every day (QD).
4 mg BaricitinibBaricitinibParticipants received one 4 mg Baricitinib tablet and one placebo tablet matching 2 mg Baricitinib administered orally QD.
2 mg BaricitinibBaricitinibParticipants received one 2 mg Baricitinib tablet and one placebo tablet matching 4 mg Baricitinib administered orally every day (QD).
Placebo to 2 mg BaricitinibBaricitinibParticipants who received placebo in the originating study (JAHZ or JAIA) were randomized to receive 2 mg Baricitinib administered orally QD.
Placebo to 4 mg BaricitinibBaricitinibParticipants who received placebo in the originating study (JAHZ or JAIA) were randomized to receive 4 mg Baricitinib administered orally QD.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With Permanent Investigational Product DiscontinuationsWeek 134

Percentage of participants with permanent investigational product discontinuations.

Percentage of Participants With Serious Adverse Events (SAEs)Week 134

Percentage of participants with SAEs. An SAE is any AE from this study that results in one of the following outcomes: Death; Initial or prolonged inpatient hospitalization; A life-threatening experience (that is, immediate risk of dying); Persistent or significant disability/incapacity; Congenital anomaly/birth defect; Important medical events that may not be immediately life-threatening or result in death or hospitalization, but may jeopardize the patient or may require intervention to prevent one of the other outcomes listed in the definition above.

A summary of all SAE's, regardless of causality, is located in the Reported Adverse Events section.

Percentage of Participants With Temporary Investigational Product InterruptionsWeek 134

Percentage of participants with temporary investigational product interruptions.

Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)Week 134

Percentage of participants with TEAEs. A treatment-emergent AE (TEAE) is defined as an event that first occurred or worsened in severity after the first dose of study treatment in Study JAIM and on or prior to the last visit date during the analysis period. The analysis period is defined as the treatment period plus up to 30 days off-drug follow-up time.

A summary of serious and other non-serious adverse events, regardless of causality, is located in the Reported Adverse Events module.

Percentage of Participants With Adverse Events of Special Interest (AESIs)Week 134

Percentage of Participants with AESIs. AESI consisted of infections, positively adjudicated arterial thromboembolic events (ATE), positively adjudicated venous thromboembolic events (VTE), positively adjudicated major adverse cardiovascular events (MACE), other positively adjudicated cardiovascular events, death, anaphylactic reactions, hypersensitivity, angioedema, and malignancies.

Secondary Outcome Measures
NameTimeMethod
Annualized Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA)-Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) Flare Index Flare RateBaseline through Week 48

The SELENA-SLEDAI tool is a cumulative and weighted index used to assess disease activity across 24 different disease descriptors in patients with lupus. A patient's SELENA-SLEDAI total score is the sum of all marked lupus related descriptors (seizure, psychosis, organic brain syndrome, visual disturbance, cranial nerve disorder, lupus headache, cerebrovascular accident, vasculitis, arthritis, myositis, urinary casts, hematuria, proteinuria, pyuria, new rash, alopecia, mucosal ulcers, pleurisy, pericarditis, low complement, increased DNA binding, fever, thrombocytopenia, leukopenia). A total score can fall between 0 and 105, with a higher score representing a more significant degree of disease activity. The annualized flare rate is calculated as the number of flares divided by the flare exposure time in days multiplied with 365.25.

Percentage of Participants With Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) Total Activity Score ≥10 at Baseline With ≥50% Reduction in CLASI Total Activity ScoreWeek 48

The CLASI is a single-page tool that separately quantifies disease activity and damage. For the activity score, points are given for the presence of erythema, scale, mucous membrane lesions, recent hair loss, and inflammatory alopecia. The total score represents the sum of the individual scores and ranges from 0 to 70. Higher scores are awarded for more severe manifestations.

Percentage of Participants Achieving a Systemic Lupus Erythematosus Responder Index 4 (SRI-4) ResponseWeek 134

SRI-4 response defined as 1)greater than or equal to 4-point reduction in Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) total score 2)no new British Isles Lupus Assessment Group (BILAG) A and no more than 1 new BILAG B domain score and 3)no worsening in Physician Global Assessment (PGA) of Disease Activity (worsening defined as an increase of \>=0.3 from baseline on a 0-3 visual analogue scale).

SLEDAI-2K assessment consists of 24 items with total score of 0(no symptoms) to 105 (presence of all defined symptoms) with higher scores representing increased disease activity. BILAG Index: assessing clinical signs, symptoms,or laboratory parameters related to Systemic Lupus Erythematosus (SLE),divided into 9 organ systems. For each organ system A=severe disease,B=moderate disease,C=mild stable disease,D=inactive,but previously active,E=inactive and never affected. PGA assesses disease activity on a visual analogue scale from 0 to 3 (1=mild, 2=moderate, 3=severe).

Change From Baseline in Tender Joint CountBaseline through Week 48

The number of tender and painful joints is determined by examination of 28 joints (14 on each side) which include: the 2 shoulders, the 2 elbows, the 2 wrists, the 10 metacarpophalangeal joints, the 2 interphalangeal joints of the thumb, the 8 proximal interphalangeal joints, and the 2 knees. The joints are assessed and classified as tender or not tender. LS mean was calculated using Mixed Model Repeated Measures (MMRM) analysis with treatment, baseline disease activity (total SLEDAI-2K \<10; \>=10), baseline corticosteroid dose (\<10 mg/day; \>=10 mg/day prednisone or equivalent), region (North America, Central/South America/Mexico, Europe, Asia and Rest of World), visit (as categorical variable), baseline value, treatment-by-visit interaction, and baseline value-by-visit interaction.

Change From Baseline in Swollen Joint CountBaseline trough Week 48

The number of swollen joints is determined by examination of 28 joints (14 on each side) which include: the 2 shoulders, the 2 elbows, the 2 wrists, the 10 metacarpophalangeal joints, the 2 interphalangeal joints of the thumb, the 8 proximal interphalangeal joints, and the 2 knees. The joints are assessed and classified as swollen or not swollen. LS mean was calculated using MMRM analysis with treatment, baseline disease activity (total SLEDAI-2K \<10; \>=10), baseline corticosteroid dose (\<10 mg/day; \>=10 mg/day prednisone or equivalent), region (North America, Central/South America/Mexico, Europe, Asia and Rest of World), visit (as categorical variable), baseline value, treatment-by-visit interaction, and baseline value-by-visit interaction.

Change From Baseline in Worst Pain Numeric Rating Scale (NRS)Baseline through Week 48

Change from baseline in Worst Pain NRS. It is assessed using an 11-point Numeric Rating Scale (NRS) (0-10) where 0 represents "no pain" and 10 represents "worst pain imaginable". Overall severity of a patient's pain is indicated by selecting the number that best describes the worst level of pain during the past 7 days.

Percentage of Participants Achieving a Lupus Low Disease Activity State (LLDAS)Week 48

Percentage of participants achieving a LLDAS. The LLDAS is a composite measure designed to identify patients achieving a state of low disease activity. The LLDAS response criteria were: (1) SLEDAI-2K \<=4, with no activity in major organ systems (CNS, vascular, renal, cardiorespiratory and constitutional); where "no activity" is defined as all items of SLEDAI-2K within these major organ systems equal to 0. (2) no new features of lupus disease activity compared to previous occurred visit, where the "new feature" is defined as any of the SLEDAI-2K 24 items changed from 0 to greater than 0; (3) PGA (scale 0-3), \<=1; (4) current prednisolone (or equivalent) dose \<=7.5 mg daily.

Change From Baseline in Prednisone DoseBaseline through Week 48

Change from baseline in prednisone dose.

Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Total ScoreBaseline through Week 48

The SLICC/ACR damage index is a validated instrument to assess damage, defined as irreversible impairment, continuously persistent for 6 months (ascertained by clinical assessment), occurring since the onset of lupus, and it is based on a weighted scoring system. This index records damage occurring in participants with SLE regardless of cause, with demonstrated content, face, criterion, and discriminant validity. A score of 0 indicates no damage. Total maximum score is 47 and increasing score indicates increasing disease severity.

Trial Locations

Locations (296)

New England Research Associates

🇺🇸

Bridgeport, Connecticut, United States

Metroplex Clinical Research Center

🇺🇸

Dallas, Texas, United States

Integral Rheumatology & Immunology Specialists

🇺🇸

Plantation, Florida, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Millennium Research

🇺🇸

Ormond Beach, Florida, United States

North Georgia Rheumatology, PC

🇺🇸

Lawrenceville, Georgia, United States

Paramount Medical Research

🇺🇸

Middleburg Heights, Ohio, United States

Johns Hopkins Asthma and Allergy Center

🇺🇸

Baltimore, Maryland, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

MD Medical Corporation

🇺🇸

Hemet, California, United States

Advanced Rheumatology, PC

🇺🇸

Lansing, Michigan, United States

The Feinstein Institute for Medical Research

🇺🇸

Manhasset, New York, United States

St. Lawrence Health System

🇺🇸

Canton, New York, United States

ACRC Studies

🇺🇸

Poway, California, United States

Arthritis and Osteoporosis Associates of New Mexico

🇺🇸

Las Cruces, New Mexico, United States

Allied Clinical Research

🇺🇸

Reno, Nevada, United States

NYU Langone

🇺🇸

New York, New York, United States

Wallace Rheumatic Studies Center

🇺🇸

Beverly Hills, California, United States

Clinical Research Institute of Michigan, LLC

🇺🇸

Saint Clair Shores, Michigan, United States

Immanuel Krankenhaus Rheuma Klinik Berlin Buch

🇩🇪

Berlin, Germany

Charité Campus Virchow-Klinikum

🇩🇪

Berlin, Germany

University General Hospital of Heraklion

🇬🇷

Heraklion, Irakleío, Greece

Debreceni Egyetem Klinikai Kozpont

🇭🇺

Debrecen, Hungary

Gen. Hosp. of Thessaloniki "Hippokration"

🇬🇷

Thessaloniki, Greece

Azienda Ospedaliera Santa Maria Della Misericordia

🇮🇹

Udine, Italy

Universitatsklinikum Leipzig

🇩🇪

Leipzig, Sachsen, Germany

Universitaetsklinikum Koeln

🇩🇪

Köln, Germany

Qualiclinic

🇭🇺

Budapest, Hungary

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Azienda Policlinico Umberto I

🇮🇹

Roma, Italy

Cantonal Hospital St.Gallen

🇨🇭

st.Gallen, Sankt Gallen, Switzerland

Hualien Tzu-Chi Hospital

🇨🇳

Dalin Township, Taiwan

Showa University Hospital

🇯🇵

Shinagawa, Tokyo, Japan

Gachon University Gil Hospital

🇰🇷

Incheon, Korea, Korea, Republic of

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Barcelona [Barcelona], Spain

Mary Mediatrix Medical Center

🇵🇭

Lipa, Batangas, Philippines

Jakaranda Hospital

🇿🇦

Pretoria, Gauteng, South Africa

Hanyang University Medical Center

🇰🇷

Seoul, Korea, Korea, Republic of

Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Korea, Republic of

Morales Vargas Centro de Investigacion, S.C.

🇲🇽

Leon, Guanajuato, Mexico

Clinica para el Diagnostico y Tratamiento de la Enfermedades

🇲🇽

Mexico City, Distrito Federal, Mexico

Kyung Pook National University Hospital

🇰🇷

Daegu, Korea, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Korea, Republic of

WITS Clinical Research

🇿🇦

Johannesburg, Gauteng, South Africa

Zespol Poradni Specjalistycznych REUMED

🇵🇱

Lublin, Polska, Poland

University Of Pretoria

🇿🇦

Pretoria, South Africa

Suite 509 Umhlanga Netcare Medical Centre

🇿🇦

Umhlanga, Durban, South Africa

Whipps Cross University Hospital

🇬🇧

Leytonstone, London, United Kingdom

Chi-Mei Medical Center

🇨🇳

Tainan City, Taiwan

Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

🇬🇧

Doncaster, United Kingdom

Rheumatology Center Of Houston

🇺🇸

Houston, Texas, United States

Arthritis Clinic of Northern VA, P.C.

🇺🇸

Arlington, Virginia, United States

Spectrum Medical Inc.

🇺🇸

Danville, Virginia, United States

Rheumatic Disease Center

🇺🇸

Glendale, Wisconsin, United States

Medvin Clinical Research - Weidmann

🇺🇸

Whittier, California, United States

Providence Medical Foundation

🇺🇸

Fullerton, California, United States

Arthritis and Rheumatic Disease

🇺🇸

Aventura, Florida, United States

Clinical Research of West Florida, Inc. (Clearwater)

🇺🇸

Clearwater, Florida, United States

Lakes Research, LLC

🇺🇸

Miami Lakes, Florida, United States

IRIS Research and Development, LLC

🇺🇸

Plantation, Florida, United States

SUNY Upstate Medical University

🇺🇸

Syracuse, New York, United States

Joint and Muscle Medical Care

🇺🇸

Charlotte, North Carolina, United States

Medication Management

🇺🇸

Greensboro, North Carolina, United States

Box Arthritis & Rheumatology of the Carolinas, PLLC

🇺🇸

Charlotte, North Carolina, United States

Cincinnati Rheumatic Disease Study Group

🇺🇸

Cincinnati, Ohio, United States

East Penn Rheumatology Associates

🇺🇸

Bethlehem, Pennsylvania, United States

Clinical Research Center of Reading,LLC

🇺🇸

Wyomissing, Pennsylvania, United States

Eagle Medical

🇺🇸

Crossville, Tennessee, United States

Articularis Healthcare d/b/a/ Low Country Rheumatology, PA

🇺🇸

Summerville, South Carolina, United States

Amarillo Center for Clinical Research

🇺🇸

Amarillo, Texas, United States

Accurate Clinical Management

🇺🇸

Baytown, Texas, United States

Dr. Dhiman Basu Private Practice

🇺🇸

Colleyville, Texas, United States

Precision Comprehensive Clinical Research Solutions

🇺🇸

Fort Worth, Texas, United States

Accurate Clinical Research

🇺🇸

Houston, Texas, United States

Southwest Rheumatology, P.A.

🇺🇸

Mesquite, Texas, United States

Advanced Rheumatology of Houston

🇺🇸

The Woodlands, Texas, United States

Framingham Centro Medico

🇦🇷

La Plata, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Quilmes

🇦🇷

Quilmes, Buenos Aires, Argentina

Clinica Adventista Belgrano

🇦🇷

Caba, Ciudad Autónoma De Buenos Aire, Argentina

Sanatorio Británico

🇦🇷

Rosario, Santa Fe, Argentina

Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC)

🇦🇷

Buenos Aires, Argentina

IR Medical Center S.A. Instituto de Reumatologia

🇦🇷

Mendoza, Argentina

Optimus Clinical Research

🇦🇺

Botany, New South Wales, Australia

Centro de Investigaciones Médicas Tucuman

🇦🇷

Tucumán, Argentina

The Rheumatology Research Unit Sunshine Coast

🇦🇺

Maroochydore, Queensland, Australia

Emeritus Research

🇦🇺

Camberwell, Victoria, Australia

St. Vincent's Hospital

🇦🇺

Fitzroy, Victoria, Australia

A O Krankenhaus der Elisabethinen

🇦🇹

Linz, Oberösterreich, Austria

Medizinische Universität Graz

🇦🇹

Graz, Austria

UZ Leuven

🇧🇪

Leuven, Vlaams Brabant, Belgium

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Santa Casa de Misericordia de Belo Horizonte

🇧🇷

Belo Horizonte, MG, Brazil

EDUMED - Educação em Saúde Ltda.

🇧🇷

Curitiba, Paraná, Brazil

Centro de Estudos em Terapias Inovadoras-CETI

🇧🇷

Curitiba, Paraná, Brazil

Oncovida- Centro de Onco-Hematologia de Mato Grosso

🇧🇷

Cuiaba, Brazil

Enroll SpA

🇨🇱

Providencia, Región Metropolitana De Santia, Chile

Hospital de Clinicas UNICAMP

🇧🇷

Campinas, SP, Brazil

Clinical Research Chile SpA

🇨🇱

Valdivia, Los Ríos, Chile

Clinica Alemana de Osorno

🇨🇱

Osorno, Chile

Sociedad Medica Del Aparato Locomotor SA

🇨🇱

Santiago, Chile

Prosalud y cia. Ltda.

🇨🇱

Santiago, Chile

CINVEC- Estudos Clínicos Quinta Región Limitada

🇨🇱

Vina del Mar, Chile

Peking University First Hospital

🇨🇳

Beijing, China

Shanghai Huashan Hospital Affil to Fu Dan University

🇨🇳

Shanghai, China

HPTU-El Hospital con alma Pablo Tobon Uribe

🇨🇴

Medellin, Antioquia, Colombia

Clinica de la Costa

🇨🇴

Barranquilla, Atlantico, Colombia

Circaribe SAS

🇨🇴

Barranquilla, Atlántico, Colombia

Idearg S.A.S.

🇨🇴

Bogota, Cundinamarca, Colombia

Centro de Medicina Interna

🇨🇴

Cali, Valle Del Cauca, Colombia

Servimed S.A.S.

🇨🇴

Bucaramanga, Santander, Colombia

Preventive Care Ltdac

🇨🇴

Chia, Colombia

Klinicki Bolnicki Centar Rijeka

🇭🇷

Rijeka, Croatia

University Hospital Split

🇭🇷

Split, Croatia

Revmatologicky ustav

🇨🇿

Praha 2, Praha, Hlavní Mešto, Czechia

Revmatologie.s.r.o.

🇨🇿

Brno, Czechia

Fakultni nemocnice Olomouc

🇨🇿

Olomouc, Czechia

VFN a 1 LF University Karlovy

🇨🇿

Praha 2, Czechia

Centre hospitalier universitaire Pellegrin

🇫🇷

Bordeaux, France

ARTHROHELP s.r.o.

🇨🇿

Pardubice, Czechia

CHRU Brest - Hopital Cavale Blanche

🇫🇷

Brest Cedex, Finistère, France

CHRU Lille - Hopital Claude Huriez

🇫🇷

Lille Cedex, France

Hôpital de HautePierre

🇫🇷

Strasbourg, France

Universitätsklinikum Freiburg

🇩🇪

Freiburg, Baden-Württemberg, Germany

Klinikum der Universität München Großhadern

🇩🇪

München, Bayern, Germany

Universitätsklinikum Tübingen

🇩🇪

Tübingen, Baden-Württemberg, Germany

Universitätsklinikum Würzburg A. ö. R.

🇩🇪

Würzburg, Bayern, Germany

Universitätsmedizin Johannes Gutenberg Universität Mainz

🇩🇪

Mainz, Rheinland-Pfalz, Germany

Universitätsklinikum Carl Gustav Carus

🇩🇪

Dresden, Sachsen, Germany

Krishna Institute of Medical Science

🇮🇳

Secunderabad, Telengana, India

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

Azienda Ospedaliera Universitaria Pisana

🇮🇹

Pisa, Italy

Hokkaido University Hospital

🇯🇵

Sapporo, Hokkaido, Japan

Seirei Hamamatsu General Hospital

🇯🇵

Hamamatsu, Shizuoka, Japan

Juntendo University Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

Hamanomachi Hospital

🇯🇵

Fukuoka, Japan

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Korea, Republic of

Gabinet Internistyczno- Reumatologiczny Piotr Adrian Klimiuk

🇵🇱

Bialystok, Podlaskie, Poland

Winelands Medical Research Centre

🇿🇦

Stellenbosch, Western Cape, South Africa

Hospital De Fuenlabrada

🇪🇸

Fuenlabrada, Madrid, Spain

Hospital do Meixoeiro

🇪🇸

Vigo, Pontevedra, Spain

Hospital Quiron Infanta Luisa

🇪🇸

Sevilla, Spain

Corporació Sanitària Clínic

🇪🇸

Barcelona, Spain

St George's Hospital

🇬🇧

Tooting, London, United Kingdom

Leeds Teaching Hospital

🇬🇧

Leeds, United Kingdom

First affiliated Hospital of Sun Yat-Sen University

🇨🇳

Guangzhou, Guangdong, China

First Affiliated Hospital of the Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

Pingxiang People's Hospital

🇨🇳

Pingxiang, Jiangxi, China

Wuhan Union Hospital

🇨🇳

Wuhan, Hubei, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School

🇨🇳

Nanjing, Jiangsu, China

China-Japan Union Hospital, CJUH.

🇨🇳

Changchun, Jilin, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, Tianjin, China

People's Hospital of Xinjiang Uygur Autonomous Region

🇨🇳

Urumqi, Xinjiang, China

Zhongshan Hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

The Second Affiliated Hospital of Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

Ningbo First Hospital

🇨🇳

Ningbo, Zhejiang, China

Beijing Peking Union Medical College Hospital

🇨🇳

Beijing, China

China Medical University (CMU) - First Affiliated Hospital

🇨🇳

Shenyang, China

The First Affliated Hospital of Suzhou University

🇨🇳

Suzhou Shi, China

The First Affiliated Hospital of Zhengzhou Universtiy

🇨🇳

Zhengzhou, China

Cemdeicy S.C.P.

🇲🇽

Merida, Yucatán, Mexico

Centro Peninsular de Investigacion S.C.P

🇲🇽

Merida, Yucatán, Mexico

SER - Serviços Especializados em Reumatologia da Bahia S/S - ME

🇧🇷

Salvador, Bahia, Brazil

LMK Serviços Médicos S/S

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Maidstone Hospital

🇬🇧

Maidstone, Kent, United Kingdom

Fortis Escorts Hospital

🇮🇳

Jaipur, Rajasthan, India

Aprillus Asistencia e Investigacion de Arcis Salud SRL

🇦🇷

Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina

Piedmont Healthcare

🇺🇸

Atlanta, Georgia, United States

West Tennessee Research Institute

🇺🇸

Jackson, Tennessee, United States

Arizona Arthritis & Rheumatology Associates, P. C.

🇺🇸

Tucson, Arizona, United States

Glacir View Research Institute

🇺🇸

Kalispell, Montana, United States

DOM Centro de Reumatologia

🇦🇷

Ciudad de Buenos Aires, Buenos Aires, Argentina

CER Instituto Medico

🇦🇷

Quilmes, Buenos Aires, Argentina

Békés Megyei Központi Kórház Pándy Kálmán Tagkórház

🇭🇺

Gyula, Békés, Hungary

Budai Irgalmasrendi Korhaz

🇭🇺

Budapest, Hungary

Gen Hospital of Athens G Gennimatas

🇬🇷

Athens, Attiki, Greece

Kianous Stavros

🇬🇷

Thessaloniki, Greece

Regional General University Hospital of Larissa

🇬🇷

Larissa, Greece

Vital Medical Center

🇭🇺

Veszprem, Veszprém City, Hungary

Debreceni Egyetem Orvos-es Egészsegtudomanyi Centrum

🇭🇺

Debrecen, Hungary

Pecsi Tudomanyegyetem Klinikai Kozpont

🇭🇺

Pecs, Hungary

CIMS Hospital Private Limited

🇮🇳

Ahmedabad, Gujarat, India

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet

🇭🇺

Budapest, Hungary

Panchshil hospital

🇮🇳

Ahmedabad, Gujarat, India

St. John Medical College & Hospital

🇮🇳

Bangalore, Karnataka, India

Sushruta Multispecialty Hospital & Research Center Pvt Ltd

🇮🇳

Hubli, Karnataka, India

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Nirmal Hospital Private Limited

🇮🇳

Surat, Gujarat, India

Synexus Affiliate - Sujata Birla Hospital & Medical Research Center

🇮🇳

Nashik, Maharashtra, India

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Belgyogyaszati Klinika

🇭🇺

Szeged, Hungary

Vita Verum Egeszsegugyi Szolgaltato Bt

🇭🇺

Székesfehérvár, Hungary

ChanRe Rheumatology And Immunology Center And Research

🇮🇳

Bangalore, Karnataka, India

Sterling Hospital

🇮🇳

Vadodara, Gujarat, India

Kasturba Medical College Hospital, Mangalore

🇮🇳

Madhav Nagar, Manipal, Karnataka, India

Shree Giriraj Hospital

🇮🇳

Rajkot, Gujarat, India

Carmel Hospital

🇮🇱

Haifa, Ḥeifā, Israel

Jasleen Hospital

🇮🇳

Nagpur, Maharashtra, India

University of Occupational and Enviromental Health

🇯🇵

Kitakyushu, Fukuoka, Japan

St. Luke's International Hospital

🇯🇵

Tokyo, Japan

National Hospital Organization Asahikawa Medical Center

🇯🇵

Asahikawa, Hokkaido, Japan

Kobe University Hospital

🇯🇵

Kobe, Hyogo, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

Tomishiro Central Hospital

🇯🇵

Tomigusuku, Okinawa, Japan

Jp Red Cross Society Himeji Hp

🇯🇵

Himeji, Hyogo, Japan

Kagawa University Hospital

🇯🇵

Kita-gun, Kagawa, Japan

Keio university hospital

🇯🇵

Tokyo, Japan

Tohoku University Hospital

🇯🇵

Sendai-shi, Miyagi, Japan

Nippon Medical School Hospital

🇯🇵

Bunkyo-Ku, Tokyo, Japan

National Hospital Organization Kyushu Medical Center

🇯🇵

Fukuoka, Japan

Consultorio Jose Luis Garcia Figueroa

🇲🇽

Villahermosa, Tabasco, Mexico

Dr. Alberto Esteban Bazzoni Ruiz

🇲🇽

Torreon, Coahuila, Mexico

Clinosar Mexico S.A. de C.V

🇲🇽

Mexico City, Mexico

Centro Integral en Reumatologia SA de CV

🇲🇽

Guadalajara, Jalisco, Mexico

Clinica de Investigacion en Reumatologia y Obesidad S. C.

🇲🇽

Guadalajara, Jalisco, Mexico

Medische Centrum Leeuwarden

🇳🇱

Leeuwarden, Fryslân, Netherlands

Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V.

🇲🇽

Zapopan, Jalisco, Mexico

Centro de Alta Especialidad Reumatologia Inv del Potosi SC

🇲🇽

San Luis Potosi, SLP, Mexico

Consultorio de Reumatologia

🇲🇽

Mexico City, Mexico

Chong Hua Hospital

🇵🇭

Cebu City, Cebu, Philippines

Centro de Estudios de Investigacion Metabolicos y Cardiovasculares

🇲🇽

Guadalajara, Jalisco, Mexico

Köhler & Milstein Research

🇲🇽

Merida, Yucatan, Mexico

Centro de Investigación y Tratamiento Reumatológico S.C

🇲🇽

Ciudad De México, Mexico

Oaxaca Site Management Organization

🇲🇽

Oaxaca, Mexico

Vrije Universiteit Medisch Centrum Amsterdam

🇳🇱

Amsterdam, Netherlands

Klinika Reumatologii, Chorob Wewnetrznych i Geriatrii PUM

🇵🇱

Szczecin, Poland

Cebu Doctors Hospital

🇵🇭

Cebu City, Cebu, Philippines

Makati Medical Center

🇵🇭

Makati, Luzon, Philippines

Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy, Klinika Reumatologii i Chorob Tkanki Lacznej

🇵🇱

Bydgoszcz, Kujawsko-pomorskie, Poland

Reumatika - Centrum Reumatologii

🇵🇱

Warszawa, Mazowieckie, Poland

Southern Philippines Medical Center

🇵🇭

Davao, Davao Del Norte, Philippines

St. Luke's Medical Center

🇵🇭

Quezon City, Luzon, Philippines

Angeles University Foundation and Medical Center

🇵🇭

Angeles City, Pampanga, Philippines

Twoja Przychodnia Centrum Medyczne Nowa Sol

🇵🇱

Nowa Sol, Lubuskie, Poland

Napoca Emergency Clinical County Hospital

🇷🇴

Napoca, Cluj, Romania

Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o.

🇵🇱

Wroclaw, Dolnoslaskie, Poland

Medycyna Kliniczna

🇵🇱

Warszawa, Mazowieckie, Poland

Centrum Medyczne Pratia Katowice

🇵🇱

Katowice, Poland

Klinika Reumatologii i Rehabilitacji

🇵🇱

Poznan, Poland

Chelyabinsk Regional Clinical Hospital

🇷🇺

Chelyabinsk, Russian Federation

Centrum Medyczne AMED

🇵🇱

Warszawa, Poland

Spitalul Clinic "Dr. Ioan Cantacuzino"

🇷🇴

Bucuresti, Romania

Orenburg State Medical Academy of Roszdrav

🇷🇺

Orenburg, Russian Federation

Ambulatorium Barbara Bazela

🇵🇱

Elblag, Warminsko-Mazurki, Poland

Centrum Medyczne Plejady

🇵🇱

Krakow, Poland

Craiova Emergency Clinical County Hospital

🇷🇴

Craiova, Dolj, Romania

Spitalul Clinic Sf Maria Bucuresti

🇷🇴

Bucuresti, Romania

MCM Krakow - PRATIA - PPDS

🇵🇱

Krakow, Poland

NZOZ Lecznica MAK-MED s.c.

🇵🇱

Nadarzyn, Poland

V.A. Nasonova Research Institute of Rheumatology

🇷🇺

Moscow, Russian Federation

C.M.D.T.A. Neomed

🇷🇴

Brasov, Brașov, Romania

Spitalul Euroclinic

🇷🇴

Bucureti, București, Romania

SANA Medical Center

🇷🇴

Bucharest, Romania

Moscow City Clinical Hospital Number 52

🇷🇺

Moscow, Moskva, Russian Federation

LLC MK Med

🇷🇺

St. Petersburg, Saint Petersburg, Russian Federation

Institute of Cytology and Genetics of Siberian Branch of Russian Academy of Medical Sciences

🇷🇺

Novosibirsk, Russian Federation

Kursk Regional Clinical Hospital

🇷🇺

Rursk, Russian Federation

Russian National Research Medical University n.a. N.I.Pirogov

🇷🇺

Moscow, Russian Federation

City Hospital # 7

🇷🇺

Kazan, Russian Federation

Research Institute of Clinical Immunology

🇷🇺

Novosibirsk, Russian Federation

Regional Hospital - Omsk

🇷🇺

Omsk, Russian Federation

Military Medical Academy

🇷🇸

Belgrade, Serbia

Hospital Marina Baixa

🇪🇸

La Vila Joiosa, Alicante, Spain

Kuvatov Republican Clinical Hospital

🇷🇺

Ufa, Russian Federation

Institute for Treatment and Rehabilitation Niska Banja

🇷🇸

Niska Banja, Serbia

Ryazan State Medical University

🇷🇺

Ryazan, Russian Federation

Departmental Hospital at Smolensk Station "rzhd" JSC

🇷🇺

Smolensk, Russian Federation

Russian Medical Military Academy n.a. S.M. Kirov

🇷🇺

Saint Petersburg, Russian Federation

LLC Medical Center Zdorovaya Semiya

🇷🇺

Zonova, Russian Federation

Vincent Pallotti Hospital

🇿🇦

Cape Town, Western Cape, South Africa

Panorama Medical Centre

🇿🇦

Cape Town, Western Cape, South Africa

Institute of Rheumatology

🇷🇸

Belgrade, Serbia

University Clinical Center of Serbia

🇷🇸

Belgrade, Serbia

Kaohsiung Veterans General Hospital

🇨🇳

Kaohsiung, Taiwan

China Medical University Hospital

🇨🇳

Taichung, Taiwan

Clinical Center of Vojvodina

🇷🇸

Novi Sad, Serbia

Chang Gung Memorial Hospital - Linkou

🇨🇳

Taoyuan City, Taiwan

Chang Gung Memorial Hospital - Kaohsiung Branch

🇨🇳

Kaohsiung, Taiwan

Corporacion Sanitaria Parc Tauli

🇪🇸

Sabadell, Barcelona, Spain

Taichung Veterans General Hospital

🇨🇳

Taichung, Taiwan

Guys/St. Thomas Hospital

🇬🇧

London, Surrey, United Kingdom

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Taipei Medical University Hospital

🇨🇳

Taipei, Taiwan

Hopital Européen

🇫🇷

Marseille, France

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

Achieve Clinical Research, LLC

🇺🇸

Birmingham, Alabama, United States

Arizona Arthritis & Rheumatology Research

🇺🇸

Phoenix, Arizona, United States

Denver Arthritis Clinic - Lowry

🇺🇸

Denver, Colorado, United States

Arthritis & Rheumatology Center of Oklahoma PLLC

🇺🇸

Oklahoma City, Oklahoma, United States

Oklahoma Medical Research Foundation

🇺🇸

Oklahoma City, Oklahoma, United States

Accurate Clinical Research, Inc.

🇺🇸

San Antonio, Texas, United States

ForCare Clinical Research

🇺🇸

Tampa, Florida, United States

Tampa Medical Group, P.A.

🇺🇸

Tampa, Florida, United States

Arthritis Center of Lexington

🇺🇸

Lexington, Kentucky, United States

Inland Rheumatology & Osteoporosis Medical Group

🇺🇸

Upland, California, United States

Schlosspark Klinik

🇩🇪

Berlin, Germany

City Clinical Hospital 1 named after N.I. Pirogov

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath